Purchase Order 75F40124P00019
Award Date
12/21/23
Potential Completion Date
12/19/28
Potential Value
$170K
Federal Agency
Food and Drug Administration
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Lakewood, CO 80225, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $58,464.00 firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Illumina, Inc. for preventive maintenance services on two (2) Illumina MiSeq instruments. The award has an ultimate completion date of July 19, 2027 and does not utilize any set-aside designations. Illumina is a manufacturer of genomic sequencing instruments and reagents, and has been awarded numerous past federal prime contracts and subcontracts across agencies such as the NIH, CDC, USDA,...
This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a manufacturer of sequencing and genomic analysis solutions. The contract, valued at $89,573.00, is for preventative maintenance and repair services for the agency's MiSeq sequencing system. The contract has an ultimate completion date of April 30, 2028 and does not include any set-aside designation. Illumina has previously provided a range of sequencing instruments, reagents, and...
This is a firm fixed price purchase order awarded by the Food and Drug Administration (FDA) to Illumina, Inc. for an annual maintenance agreement covering seven Illumina sequencing instruments. The contract has a base year and four option years, with a total potential value of $817,521.04. Illumina, a manufacturer of sequencing and genomic analysis technologies, has a history of providing sequencing systems, reagents, and maintenance services to federal agencies for various research and...
This firm fixed-price delivery order, valued at $201,939.00, was awarded by the Food and Drug Administration (FDA) to Illumina, Inc. for preventative maintenance services on MiSeq benchtop sequencing instruments. The award does not have a set-aside designation. Illumina is a manufacturer of genetic sequencing systems and has a history of supporting genomic research and diagnostics across multiple federal agencies. This award indicates Illumina is providing maintenance services to help ensure the...
This is a firm fixed price delivery order awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract, valued at $21,183, is for the provision of preventative maintenance services for Illumina's MiSeq benchtop sequencer. The contract does not have a set-aside designation. Illumina has extensive experience providing sequencing systems, reagents, and maintenance services to a variety of...
The Department of Health and Human Services Food and Drug Administration awarded a $67,963.80 firm fixed price purchase order to Illumina, Inc. for corrective, remedial, repair, and preventive maintenance services for Illumina's MiSeq sequencing systems. The contract has a period of performance through February 28, 2025 and was awarded on December 12, 2019. No set-aside designation was used for this award to support the FDA's medical device evaluation programs through ongoing maintenance and...
This is a firm fixed price purchase order awarded by the Food and Drug Administration (FDA) to Illumina, Inc. for maintenance and repair services on an Illumina MiSeq instrument at the FDA's Winchester Engineering and Analytical Center. The contract has a ceiling value of $76,208.00 and a period of performance through June 29, 2026. This was a full and open requirement with no set-aside designation. Illumina has received prior federal contract awards to provide sequencing instruments,...
This firm fixed-price purchase order was awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents, to provide a diagnostic check and system upgrades for the MiSeq Whole Genome Sequencer at six FDA laboratories. The $84,733.20 contract has a completion date of December 31, 2022 and was sole-sourced to Illumina due to the proprietary nature of the MiSeq technology. Illumina has previously provided sequencing systems,...
This firm fixed price delivery order was awarded by the Department of Health and Human Services Food and Drug Administration to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The contract is for preventative maintenance on a MiSeq benchtop sequencer, with a potential value of $26,157.45 and a completion date of September 29, 2018. Illumina has a history of providing sequencing systems and related products and services to support genomic research and diagnostics at...
This is a firm fixed price delivery order contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc. for preventative maintenance services on MiSeq benchtop sequencing instruments. The $184,226.00 contract has an ultimate completion date of December 5, 2016. Illumina is a for-profit manufacturer and provider of genomic sequencing and analysis solutions. Through prior federal contracts, Illumina has supplied a range of sequencing systems, reagents, and related services to...